Related Experiment Video
Updated: Jul 31, 2025

Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
Published on: May 26, 2023
Optimizing opioid prescribing practices after minimally invasive lung resection through a quality-improvement
Evan Barber1, Melissa Whidden2, Francisco Aguirre2
1From the Section of Thoracic Surgery, Department of Surgery, University of Calgary, Calgary, Alta. (Barber, Graham); and Alberta Health Services, Edmonton, Alta. (Whidden, Aguirre) evan.barber@gmail.com.
Background:
In their 2019 guideline on the prescribing and management of opioids after elective ambulatory thoracic surgery, the Canadian Association of Thoracic Surgeons (CATS) recommended 120 morphine milligram equivalents (MME) after minimally invasive (video-assisted thoracoscopic surgery [VATS]) lung resection. We conducted a quality-improvement project to optimize opioid prescribing after VATS lung resection.
Methods:
We assessed baseline prescribing practices for opioid-naive patients. Using a mixed-methods approach, we selected 2 quality-improvement interventions: formal incorporation of the CATS guideline into our postoperative care pathway, and development of a patient information handout regarding opioids. The intervention was initiated on Oct. 1, 2020, and was formally implemented on Dec. 1, 2020. The outcome measure was average MME of discharge opioid prescriptions, the process measure was proportion of discharge prescriptions exceeding the recommended dosage, and the balancing measure was opioid prescription refills. We analyzed the data using control charts, and compared all measures between the pre-intervention (12 mo before) and postintervention (12 mo after) groups.
Results:
A total of 348 patients who underwent VATS lung resection were identified, 173 before the intervention and 175 after the intervention. Significantly less MME was prescribed after the intervention (100 v. 158, p < 0.001), and a lower proportion of prescriptions were nonadherent to the guideline (18.9% v. 50.9%, p < 0.001). Control charts showed special cause variation corresponding with the intervention, and system stability existed after the intervention. There was no statistically significant difference in the proportion or dosage of opioid prescription refills after the intervention.
Conclusion:
After implementation of the CATS opioid guideline, there was a significant reduction in opioids prescribed at discharge and no increase in opioid prescription refills. Control charts are a valuable resource for monitoring outcomes on an ongoing basis and for assessing the effects of an intervention.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
COPD: Management Using Bronchodilators and Corticosteroids

